**(See the Editorial Commentary by Barenkamp on pages 10--11.)**

Viral upper respiratory tract infection (URTI) affects all ages but is particularly prevalent among children. Viral URTI in infants and young children is often complicated by secondary bacterial infections including acute otitis media (AOM) and acute bacterial sinusitis \[[@CIU714C1]--[@CIU714C3]\]. AOM is one of the most common diseases seen in pediatric practice and is the most common reason children receive antibiotics or undergo surgery. The incidence and causative viruses of URTI and AOM complication have been more extensively studied in children 1--5 years of age \[[@CIU714C1], [@CIU714C2]\] than in infants aged \<1 year. Early AOM onset results in recurrent and chronic otitis media later in life \[[@CIU714C4], [@CIU714C5]\]. Increased understanding of viral URTI and its association with AOM in the first year of life is essential to advance prevention efforts for this highly prevalent disease.

Advances in molecular testing such as use of polymerase chain reaction (PCR) assays have increased the detection of viruses in asymptomatic individuals. In case-control studies, respiratory viruses were detected in 58%--90% of symptomatic cases and 28%--52% of asymptomatic controls \[[@CIU714C6]--[@CIU714C10]\]. Positive PCR results in asymptomatic children may indicate acute asymptomatic viral infection, recent symptomatic infection with residual shedding, or viral persistence from past infection. The characteristics of asymptomatic respiratory viral infection in the first year of life and its association with AOM complication have not been described.

The aim of this study was to identify viruses causing asymptomatic and symptomatic URTI in infants and to establish the associations with viral load, viral coinfections, URTI symptoms, and AOM development. We tested the following hypotheses: (1) asymptomatic viral URTI in infants leads to AOM; and (2) high viral load in nasopharyngeal (NP) specimens is associated with URTI symptoms and AOM complication.

METHODS {#s2}
=======

Study Design and Subjects {#s2a}
-------------------------

The study was part of a prospective, longitudinal study of infants in the first year of life to evaluate the prevalence and risks for URTI and AOM development. The study was approved by the University of Texas Medical Branch (UTMB) Institutional Review Board; written informed consent was obtained for all subjects. Between October 2008 and April 2013, 367 subjects were enrolled. Healthy subjects living in Galveston County were recruited from the newborn nursery or primary care pediatric clinics at UTMB. Preterm infants and those with major medical problems or anatomical/physiological defects of the ear or nasopharynx were excluded. Prior to enrollment, subjects were prescreened for polymorphisms of tumor necrosis factor α (TNF^−308^) and interleukin 6 (IL-6^−174^), which we previously found to be associated with AOM susceptibility \[[@CIU714C11], [@CIU714C12]\].

Subjects were enrolled from near birth (\<1 month) and completed the study at age 6 months, if AOM developed prior to 6 months, or followed to 12 months for AOM. Upon enrollment, data were collected on family history, daycare attendance, cigarette smoke exposure, and breastfeeding vs formula feeding. Nasopharyngeal swabs were collected at 1, 2, 3, 4, 5, and 6 months, and at 9 months if the subject remained in the study.

During follow-up, parents were instructed to report to the study team when the subject developed cold (URTI) symptoms (defined below). Time and travel were compensated. Symptomatic subjects were evaluated as soon as possible after URTI onset and followed for AOM complication for 28 days. At the initial URTI visit, otoscopic examination and tympanometry were performed and NP specimens were collected for viral studies. A follow-up visit was provided 3--5 days later. Weekly telephone calls were made for follow-up of possible AOM symptoms. Parents were encouraged to bring the subject in for examination any time they suspected the infant might have an ear infection. AOM diagnosis was made based on presentations of acute symptoms (fever, irritability, otalgia), signs of tympanic membrane inflammation (intense redness, bulging, opaque tympanic membrane), and presence of middle ear fluid as documented by pneumatic otoscopy and/or tympanometry. Study personnel who made AOM diagnosis were trained and experienced otoscopists ( T. C., J. A. P., or D. P. M.).

In addition, study personnel called the parents twice monthly to identify any URTI, AOM, or lower respiratory tract infection (LRTI) missed since the last contact. A comprehensive chart review was performed at the end of follow-up to capture URTI, AOM, or LRTI episodes that may have been diagnosed by other providers. The UTMB electronic medical record, used at all UTMB sites, provided optimal capture of AOM and LRTI episodes, as UTMB is the only primary care and emergency provider for infants and children in Galveston.

Clinical Definitions {#s2b}
--------------------

### URTI Episode {#s2b1}

Presence of the following symptoms: nasal congestion, rhinorrhea, cough, and/or sore throat, with or without constitutional symptoms such as fever, decreased appetite, and restless sleep.

### Monthly Visit With Symptom History {#s2b2}

Specimens collected during monthly visit without URTI symptoms but history of URTI documented 7 days before or after specimen collection.

### Asymptomatic Viral Infection {#s2b3}

Presence of virus(es) in monthly visit specimen without history of symptoms within 7 days of specimen collection, excluding cases with the same virus detected within the previous 30 days.

### AOM Complicating URTI {#s2b4}

AOM that occurred within 28 days after the onset of URTI (unless a new-onset URTI occurred during this period; in that case, AOM was considered to have complicated the most recent URTI).

### AOM Associated With Asymptomatic Viral Infection {#s2b5}

AOM diagnosed within 28 days after asymptomatic viral infection in the absence of URTI symptoms within this time period.

Specimens {#s2c}
---------

Included in this report were respiratory specimens collected by 15 October 2013 that were available for testing by high-throughput, quantitative, multiplex PCR (HT-qPCR) assay developed for 13 respiratory viruses \[[@CIU714C13]\]. NP swab specimens were collected by trained personnel during the monthly visit by introducing a flocked swab (FLOQSwabs, COPAN, Murrieta, California) into the nose until resistance was met. The swab was rotated gently 180° and then placed in a 1-mL tube of ESwab transport medium (COPAN Diagnostics, Murrieta, California) and transported to the lab on ice within 1 hour of collection. An aliquot was sent for bacterial culture; the remaining aliquots were kept frozen at −80°C until testing. During a URTI episode, additional nasopharyngeal secretion (NPS) samples were also collected using vacuum suction into a mucus trap as previously described \[[@CIU714C13]\].

Molecular Virologic Studies {#s2d}
---------------------------

HT-qPCR assay was used in this study to detect 13 respiratory viruses including adenovirus; bocavirus; coronaviruses 229E, NL63, and OC43; enterovirus; human metapneumovirus; influenza A and B, parainfluenza viruses 1 and 3; respiratory syncytial virus (RSV); and rhinovirus. The assays were developed at the Assay Development Service Division, Galveston National Laboratory, UTMB as previously described; appropriate positive and negative controls were included \[[@CIU714C13]\]. The limit of detection (LOD) with 99% confidence was approximately 15 copies for all viruses except enterovirus and RSV, which both had an LOD of 100 copies. Viral load was calculated as viral genome copies per milliliter of the original specimen based on the original dilution of the specimens and subsequent assay dilutions.

Statistical Analysis {#s2e}
--------------------

Because each subject in the study contributed \>1 specimen, we used a generalized mixed model with logit link to analyze outcomes of symptomatic episodes; "subject" was included as a random intercept term. Other outcomes of viral detection, multiple viral detection, and AOM were also modeled and tested using the same modeling framework. Viral load was modeled using a mixed model with a log-transformed response. Grouping of patients experiencing symptomatic and asymptomatic viral detection were tested using Fisher exact test. All calculations were done in R (version 3.0.2); all mixed models were tested in the lme4 library of R.

RESULTS {#s3}
=======

Subjects and Specimens {#s3a}
----------------------

A total of 362 subjects (aged 0--12 months) yielded 2153 NP swabs or NPS specimens that were tested for viruses by HT-qPCR. Characteristics of the subjects and specimens are summarized in Table [1](#CIU714TB1){ref-type="table"}. The average duration of follow-up was 9.4 months (median, 12 months). Two hundred forty-one (66%) subjects contributed ≥6 specimens; 70 (19%) subjects contributed 3--5, and 51 (14%) contributed 1--2 specimens. In 125 of 394 (32%) URTI episodes, NP swab or NPS specimens were collected twice (average of 4 days apart), because the subjects developed AOM or continued to have symptoms. To prevent overrepresentation, the viral detection in these cases were combined. Single NP swab specimens were collected during 1634 monthly visits with no apparent symptoms; a retrospective chart review showed that URTI symptoms were present within 7 days before or after specimen collection in 147 of these cases that were subsequently reclassified as "monthly visit with symptom history." The results reported here represent 2028 URTI and monthly visit events; of these, 1487 were collected when subjects were asymptomatic (Table [2](#CIU714TB2){ref-type="table"} and [Supplementary Data](#sup1){ref-type="supplementary-material"}*A*[Supplementary Data](#sup1){ref-type="supplementary-material"}*B*). Table 1.Characteristics of the Subjects and Numbers of Specimens Tested for VirusesCharacteristicNo.%No. of subjects362Male19554Race White27576 Black8223 Asian51Ethnicity Hispanic/Latino18050Breastfed, any duration23765Cigarette smoke exposure7117Daycare attendance31TNF^-308^ polymorphism (358 tested)10429IL-6^-174^ polymorphism (359 tested)16546Subjects followed for \<6 mo4111Subjects followed 6 to \<12 mo11833Subjects followed for 12 mo20356Total duration of follow-up, patient-months3408 Total duration of follow-up, first 6 mo of life205660 Total duration of follow-up, 6--12 mo135240Total URTI episodes with virus results394 URTI episodes with 2 specimens tested for viruses125 Total URTI specimens519Total specimens collected during monthly visits1634 Month 130018 Month 226016 Month 322814 Month 423014 Month 522514 Month 624515 Month 91469Monthly specimens, symptomatic1479Monthly specimens, asymptomatic148791Total number of specimens tested for viruses2153Total URTI and monthly visit events^a^2028[^1][^2]Table 2.Virus Detection Rates by Type of SpecimensVirus TypeAllURTIMonthly VisitsSamplesSamplesWith Symptom HistoryAsymptomaticNo.%No.%No.%No.%Total2028394191477148773Virus-positive samples, %7953929976755142128Total viruses detected107945595529Single-virus samples56718059328 Rhinovirus24443^a^9955223712338 Coronaviruses^b^1202115813229228 Parainfluenza 1, 36712158584714 RSV356201161093 Metapneumovirus31513735155 Adenovirus2347423144 Enterovirus2045347113 Bocavirus2043223155 Influenza A/B71322321Multiple-virus samples228^c^1191693 2 viruses181^d^23^e^903012167919 ≥3 or more viruses47^f^6291045143[^3][^4][^5][^6][^7][^8][^9]

Detection of Viruses and Presence of Symptoms {#s3b}
---------------------------------------------

A total of 1079 viruses were detected in 795 (39%) URTI or monthly visit specimens. Virus types detected and their prevalence are shown in Figure [1](#CIU714F1){ref-type="fig"}. Virus detection rates by specimen type are shown in Table [2](#CIU714TB2){ref-type="table"}. Virus detection occurred more often during URTI, compared to monthly visits with symptom history (*P* \< .0001) and asymptomatic visits (*P* \< .00001). Multiple virus detection occurred more often in URTI samples than samples collected during asymptomatic visits (*P* \< .0001). Both positive virus detection and multiple virus detection increased with age (*P* \< .0001 and *P* \< .004, respectively). Figure 1.Proportion of respiratory viruses in 795 respiratory samples (1079 viruses) detected singly or in combination with other viruses. Rhinovirus was the most common and accounted for 40% of all detected viruses. In 567 (71%) specimens, a single virus was detected; 2 viruses were detected in 181 (23%) specimens; ≥3 viruses were identified in 47 (6%) specimens. Abbreviation: RSV, respiratory syncytial virus.

Overall, the presence of symptoms was associated with detection of virus (*P* \< .0001) and with increasing age (*P* \< .0001). Using a mixed model with random intercept (including age effect), significant positive association with symptoms was detected for rhinovirus, RSV, adenovirus, metapneumovirus (*P* ≤ .0001 for all), influenza (*P* = .007), parainfluenza (*P* = .007), and coronavirus (*P* = .014). For bocavirus and enterovirus, positive detection was not significantly associated with presence of symptoms. Table [3](#CIU714TB3){ref-type="table"} shows the estimated odds ratios for the presence of symptoms when specific viruses were detected. Detection of RSV, influenza, rhinovirus, metapneumovirus, and adenovirus were highly associated with symptoms, with odds ratios \>4. Table 3.Estimated Odds Ratios for the Presence of Symptoms When Specific Viruses Were Detected^a^VirusOdds Ratio95% Confidence IntervalRSV11.676.1--27.2Influenza A/B7.281.4--50.2Rhinovirus5.083.7--6.8Metapneumovirus4.382.3--8.5Adenovirus4.292.4--8.4Parainfluenza 1, 31.951.2--3.1Bocavirus1.86.9--3.8Coronavirus (229E, OC43, NL63)1.601.1--2.4Enterovirus1.541.0^b^--2.5[^10][^11][^12]

Repeated Viral Detection in Asymptomatic Patients {#s3c}
-------------------------------------------------

Of 1487 asymptomatic monthly specimens, 421 specimens from 242 infants were positive for 529 viruses; 328 specimens contained 1 virus, 79 had 2, and 14 had ≥ 3. Because there can be a prolonged presence of viral nucleic acids in the respiratory tract, we used available longitudinal data from each patient to establish the repeated presence of the same viruses within 30 days. Of these, 18 specimens contained 27 viruses that were detected 30 days previously and were categorized as "prolonged presence" ([Supplementary Data](#sup1){ref-type="supplementary-material"}). These results were not included in subsequent analyses. The remaining 403 specimens with positive viruses collected during asymptomatic monthly visits were considered new asymptomatic viral infections.

Asymptomatic Respiratory Viral Infections {#s3d}
-----------------------------------------

Characteristics of 403 asymptomatic viral infections in 237 infants are shown in Table [4](#CIU714TB4){ref-type="table"}. Percentage of positive specimens by month for symptomatic and asymptomatic infections is shown in Figure [2](#CIU714F2){ref-type="fig"}. There is a higher rate of asymptomatic virus detection during the Galveston non-RSV season (April to August, *P* = .04); this high rate is more pronounced in late spring and early summer (April to June, *P* = .000087). Table 4.Characteristics of 403 Asymptomatic Viral Infections in 237 InfantsCharacteristicNo.Total specimens collected from monthly asymptomatic visits1487Total specimens positive for viruses421Repeated detection of the same virus within previous 30 d By virus type27 By number of specimens18Asymptomatic viral infections403 (27%)No. of subjects with asymptomatic viral infections237Mean age4 moMedian age4 moInfections with 1 virus316 Rhinovirus119 Coronavirus NL6365 Parainfluenza 1, 343 Coronavirus OC4319 Human metapneumovirus15 Adenovirus14 Enterovirus11 Bocavirus11 Coronavirus 229E10 RSV7 Influenza A2 Influenza B0Infections with 2 viruses76Infections with 3 viruses10Infections with 4 viruses1Total viruses502AOM within 28 d of asymptomatic viral infections9AOM attributed to asymptomatic viral infections0[^13]Figure 2.Percentage of virus-positive samples (asymptomatic vs symptomatic infections) by month (combined data 2009--2013). Symptomatic infection includes upper respiratory tract infection episodes and monthly visits with symptom history.

Of 362 infants, 49 never had virus detected from their specimens, 76 had only symptomatic infections, 101 had only asymptomatic infections, and 136 had both symptomatic and asymptomatic infections. Characteristics of infants in these 4 groups are shown in [Supplementary Data](#sup1){ref-type="supplementary-material"}*A*; types of viruses detected in each group are shown in [Supplementary Data](#sup1){ref-type="supplementary-material"}*B*. Categorical data analyses of demographic, genetic, and environmental factors of infants with asymptomatic vs symptomatic infections showed association between asymptomatic infections and male sex (*P* = .004). Factors not associated with symptoms included race, ethnicity, TNF^−308^ and IL-6^−174^ polymorphisms, breastfeeding vs formula feeding, cigarette smoke exposure, and daycare attendance.

AOM Occurrences {#s3e}
---------------

A total of 111 AOM episodes were documented (Table [5](#CIU714TB5){ref-type="table"}); 95% of AOM episodes were diagnosed by the study physician; the remaining were identified through chart review. AOM complicated 27% of URTI episodes; AOM occurred in 4% of monthly visits with a symptom history. Of 1487 asymptomatic monthly visits, there were 9 AOM cases within 28 days of specimen collection. In those cases, the subjects developed URTI 8--22 days after asymptomatic specimen collection; therefore, AOM episodes were attributed to URTI and not from prior asymptomatic viral detection. Mixed-model analysis showed significant association between AOM development and increasing age (*P* \< .0001) and number of viruses detected (*P* = .009). RSV and rhinovirus, both as single and part of multiple virus detections, were associated with AOM occurrence (*P* \< .001 in all). Enterovirus (*P* \< .0001), adenovirus (*P* \< .002), and bocavirus (*P* \< .04) were also associated with AOM development marginally; coronavirus, influenza, metapneumovirus, and parainfluenza viruses were not found to be significantly associated with AOM development in this model. Table 5.Rate of Acute Otitis Media Following Upper Respiratory Tract Infection and Symptomatic and Asymptomatic Viral DetectionType of Viral InfectionTotal CasesAOM%Average Days After URTIMedian DaysBy VirusAOM%Average Days After URTIMedian DaysAfter URTIAfter URTIDetectionAfter URTIAfter URTIURTI episode3941052764Positive862954Negative192065Monthly visits, symptom history14764107Positive2377Negative45129Monthly visits, asymptomatic148700Positive00Negative00[^14]

Viral Load {#s3f}
----------

Viral load data were available for 1026 (95%) of the virus-positive specimens; 53 detections could not be accurately quantified due to unknown specimen dilution. Viral load data are shown in Figure [3](#CIU714F3){ref-type="fig"}. Overall, viral loads ranged between 2.26 × 10^−1^ and 2.35 × 10^11^ copies/mL of specimen. Median viral load in URTI specimens with AOM complication, URTI without AOM, monthly visits with symptom history, and asymptomatic monthly visit specimens was 2.85 × 10^5^, 3.63 × 10^5^, 2.5 × 10^4^, and 2.00 × 10^4^ copies/mL, respectively. Viral loads were highest in URTI groups (with or without AOM), compared with the other groups (*P* \< .00001). However, there was no significant difference in viral load in the URTI group, with and without AOM (*P* = .59). Viral load in monthly visits with symptom history specimens was not different from asymptomatic specimens (*P* = .55). For each specific virus, viral loads were also higher in URTI specimens, compared with other specimens (*P* \< .0001 for all viruses; *P* = .018 for bocavirus), except for influenza virus (no significant difference). Figure 3.Viral load by specimen type; the median is represented by the heavy horizontal line. The interquartile range is shown by the boxes. The number of specimens in each category is shown at the bottom of each column. Abbreviations: AOM, acute otitis media; URTI, upper respiratory tract infection.

DISCUSSION {#s4}
==========

In this prospective, longitudinal study of infants in the first year of life, \>2000 specimens collected from both symptomatic and asymptomatic infants were tested for the presence of 13 common viruses. Rhinovirus was the most common virus detected overall. Asymptomatic viral infection was associated with young age, male sex, low viral load, bocavirus, enterovirus, and single virus detection. Importantly, asymptomatic viral infection did not lead to AOM development.

To our knowledge, this is the largest series describing asymptomatic respiratory viral infections in infants (n = 403). Because viruses are intracellular microorganisms, detection of viruses in clinical specimens suggest replication of viruses in the host cells; thus, the term "infection" is appropriate regardless of symptoms. We defined "asymptomatic infection" by a 7-day symptom-free period before and after specimen collection; this history was carefully obtained from both parents and medical record review. This study is unique in that we utilized longitudinal data from the same infant to distinguish a new infection from repeated detection due to prolonged presence of virus nucleic acid in the respiratory tract. We used a 30-day time frame to separate the 2 situations for uniformity with previous reports \[[@CIU714C14], [@CIU714C15]\]. We are aware that survival of nucleic acid in the respiratory tract may vary depending on the virus species identified \[[@CIU714C15], [@CIU714C16]\]. Therefore, some of the defined asymptomatic viral infections in this study could still be from prolonged presence (\>30 days) of viral nucleic acids in the respiratory tract. To ascertain "new" viral infection in a successive series of positive detections of the same virus over time, sequencing of the detected viruses will be required but is beyond the scope of this report.

We found that URTI symptoms in infants associated with numerous host and virus factors and many of these factors were interrelated. Interestingly, URTI symptoms in the first year of life associated with increasing age (eg, infants 6--12 months of age expressed more symptoms than younger infants). Consistent with our finding, studies of older children \[[@CIU714C8], [@CIU714C17], [@CIU714C18]\] found that the ages of 6--12 months were a risk factor for symptoms. Collectively, these data indicate that 6- to 12-month-old infants are more likely to express symptoms than younger infants or older children. It is well known that young infants express less specific symptoms when they are ill and they are less susceptible to infections due to preexisting maternal antibodies, which wane with age. Older infants had more frequent single and multiple virus detection. Increased exposure to infections in older infants likely increases infection by multiple viruses. This may also contribute to symptom expression in older infants; association of multiple viral infections and symptoms/severity has previously been documented \[[@CIU714C8], [@CIU714C19], [@CIU714C20]\].

In this report focusing on URTI (but not LRTI), we found rhinovirus to be the most commonly detected virus in both symptomatic and asymptomatic infants. Miller et al \[[@CIU714C21]\] recently reported similar findings in 175 URTI episodes in infants (\<12 months) over 4 consecutive years. Our study also showed positive correlations between rhinovirus, symptoms, and AOM development. Other viruses highly associated with symptoms included RSV, influenza, and metapneumovirus; the seasonality of these 3 viruses may explain the higher rate of symptomatic infection during winter respiratory season and higher rate of asymptomatic infection from April to August. A recent case-control study performed in Sweden in children aged \<5 years during non--influenza season also showed high proportion of RSV and metapneumovirus in symptomatic cases \[[@CIU714C22]\]. Prolonged presence of bocavirus may partially explain a lack of association between symptoms and this virus detection \[[@CIU714C23]\].

AOM occurs mostly as a bacterial complication of viral URTI. Our finding that asymptomatic viral infection did not lead to AOM highlights the fact that a necessary step in the pathogenesis of AOM is an inflammation of the nasopharynx and the Eustachian tubes severe enough to cause URTI symptoms and associated Eustachian tube dysfunction. We clearly showed a strong correlation between expression of URTI symptoms and high viral load for all viruses except for influenza, which only accounted for a small number. Others have also shown the correlation between viral load and symptom severity of specific viruses \[[@CIU714C23]--[@CIU714C26]\]. It is interesting that the development of AOM was not associated with a higher viral load during URTI. In previous studies of an older cohort, we have also shown a lack of association between AOM complication and high viral load in metapneumovirus and bocavirus URTI \[[@CIU714C27], [@CIU714C28]\]. It is possible that viral load has lesser importance on the development of AOM when considered along with other known AOM risk factors such as demographic and genetic risks, feeding status, daycare attendance, nasopharyngeal bacterial colonization, pneumococcal antibody status, and type of URTI virus \[[@CIU714C2], [@CIU714C12], [@CIU714C29], [@CIU714C30]\].

In summary, this large study of asymptomatic respiratory viral infections in the first year of life showed rhinovirus to be the most commonly detected virus. Asymptomatic viral infection was more common in young infants and did not lead to AOM development.

Supplementary Material
======================

###### 

Click here for additional data file.
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[^1]: Abbreviations: IL-6, interleukin 6; TNF, tumor necrosis factor; URTI, upper respiratory tract infection.

[^2]: ^a^ Virus results were combined for 125 episodes for which 2 specimens were collected.

[^3]: Abbreviations: RSV, respiratory syncytial virus; URTI, upper respiratory tract infection.

[^4]: ^a^ Percentage of single virus.

[^5]: ^b^ Coronaviruses 229E, OC43, and NL63.

[^6]: ^c^ Five hundred twelve viruses.

[^7]: ^d^ Three hundred sixty-two viruses ([Supplementary Data](#sup1){ref-type="supplementary-material"}*A*).

[^8]: ^e^ Percentage of virus-positive samples (total single virus = 71%; multiple viruses = 23% + 6% = 29%).

[^9]: ^f^ One hundred fifty viruses ([Supplementary Data](#sup1){ref-type="supplementary-material"}*B*).

[^10]: Abbreviation: RSV, respiratory syncytial virus.

[^11]: ^a^ Mixed model.

[^12]: ^b^ 0.995.

[^13]: Abbreviations: AOM, acute otitis media; RSV, respiratory syncytial virus.

[^14]: Abbreviations: AOM, acute otitis media; URTI, upper respiratory tract infection.
